Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 1, 2013, Pages 51-57

  Volpe, Gretchen E ^a   Tang, Alice M ^a   Polak, Joseph F ^b   Mangili, Alexandra ^a   Skinner, Sally C ^a   Wanke, Christine A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular diseases; Heart; HIV; Progression; Viral load

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CORONARY ARTERY CALCIUM SCORE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERNAL CAROTID ARTERY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CALCIUM; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CD4 LYMPHOCYTE COUNT; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROTEASE INHIBITORS; RISK ASSESSMENT; RISK FACTORS; SMOKING; UNITED STATES; URBAN POPULATION;

EID: 84883420359     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31829ed726     Document Type: Article

References (41)

1. The Data Collection on Adverse Events of Anti-HIV Drugs Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003
2. The Writing Committee of the D:A:D Study Group. Cardio-and cerebrovascular events in HIV-infected persons. AIDS. 2004;18:1811-1817
3. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120-1126
4. Bozzette SA, Ake CF, Tam HK, et al. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med. 2003;348:702-710
5. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352:48-62
6. Ford ES, Greenwald JH, Richterman AG, et al. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS. 2010;24:1509-1517
7. Aberg JA. Cardiovascular complications in HIV management: Past, present, and future. J Acquir Immune Defic Syndr. 2009;50:54-64
8. Parra S, Coll B, Aragones G, et al. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: Relationships with serum markers of oxidation and inflammation. HIV Med. 2010;11:225-231
9. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14-22
10. Miller L, Coppola J. Noninvasive assessment of HIV-related coronary artery disease. Curr HIV/AIDS Rep. 2011;8:114-121
11. Lo J, Abbara S, Shturman L, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS. 2010;24:243-253
12. Mangili A, Polak JF, Skinner SC, et al. HIV infection and progression of carotid and coronary atherosclerosis: The CARE study. J Acquir Immune Defic Syndr. 2011;58:148-153
13. Mangili A, Gerrior J, Tang AM, et al. Risk of cardiovascular disease in a cohort of HIV-infected adults: A study using carotid intima-media thickness and coronary artery calcium score. Clin Infect Dis. 2006;43: 1482-1489
14. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410
15. O'Leary DH, Polak JF, Wolfson SK Jr, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke. 1991;22:1155-1163
16. O'Leary DH, Polak JF. Intima-media thickness: A tool for atherosclerosis imaging and event prediction. Am J Cardiol. 2002;90:18L-21L.
17. Carr JJ, Crouse JR III, Goff DC Jr, et al. Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. AJR Am J Roentgenol. 2000;174:915-921
18. Carr JJ, Danitschek JA, Goff DC, et al. Coronary artery calcium quantification with retrospectively gated helical CT: Protocols and techniques. Int J Cardiovasc Imaging. 2001;17:213-220
19. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832
20. Berry JD, Liu K, Folsom AR, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: The Coronary Artery Risk Development in Young Adults study and Multi-Ethnic study of Atherosclerosis. Circulation. 2009;119:382-389
21. Howard G, Wagenknecht LE, Burke GL, et al. Cigarette smoking and progression of atherosclerosis: The atherosclerosis risk in communities (ARIC) study. JAMA. 1998;279:119-124
22. Ranjit N, Diez-Roux AV, Chambless L, et al. Socioeconomic differences in progression of carotid intima-media thickness in the atherosclerosis risk in communities study. Arterioscler Thromb Vasc Biol. 2006;26:411-416
23. Kivimäki M, Magnussen CG, Juonala M, et al. Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: The Young Finns Study. Int J Epidemiol. 2011;40:470-478
24. Johnson HM, Douglas PS, Srinivasan SR, et al. Predictors of carotid intima-media thickness progression in young adults: The Bogalusa Heart Study. Stroke. 2007;38:900-905
25. Durga J, Bots ML, Schouten EG, et al. Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults. Am J Clin Nutr. 2011;93:941-949
26. Polak JF, Pencina MJ, Pencina KM, et al. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011;365:213-221
27. Loria CM, Liu K, Lewis CE, et al. Early adult risk factor levels and subsequent coronary artery calcification: The CARDIA study. J Am Coll Cardiol. 2007;49:2013-2020
28. Reis JP, Loria CM, Steffen LM, et al. Coffee, decaffeinated coffee, caffeine, and tea consumption in young adulthood and atherosclerosis later in life: The CARDIA study. Arterioscler Thromb Vasc Biol. 2010;30:2059-2066
29. Kingsley LA, Cuervo-Rojas J, Munoz A, et al. Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS. 2008;22:1589-1599
30. Guaraldi G, Zona S, Orlando G, et al. Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. Int J Cardiovasc Imaging. 2012;28:935-941
31. Zona S, Raggi P, Bagni P, et al. Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV. Am Heart J. 2012;163:1024-1030
32. Fitch K, Abbara S, Lee H, et al. Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome. AIDS. 2012;26:587-597
33. Ho JE, Deeks SG, Hecht FM, et al. Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals. AIDS. 2010;24:1897-1905
34. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109:1603-1608
35. Baker JV, Henry WK, Patel P, et al. Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis. 2011;53:826-835
36. Currier JS, Kendall MA, Zackin R, et al. Carotid artery intima-media thickness and HIV infection: Traditional risk factors overshadow impact of protease inhibitor exposure. AIDS. 2005;19:927-933
37. Weber C, Noels H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med. 2011;17:1410-1422
38. Hsue PY, Hunt PW, Schnell A, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009;23:1059-1067
39. Hsue PY, Scherzer R, Hunt PW, et al. Carotid intima-media thickness progression in HIV-infected adults occurs Preferentially at the carotid bifurcation and is predicted by inflammation. J Am Heart Assoc. 2012; 1:pii: Jah3-e000422
40. Mangili A, Polak JF, Quach LA, et al. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis ;214:468-473
41. Aslangul E, Fellahi S, Assoumou LK, et al. High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors. AIDS. 2011;25:1128-1131